DeSUMOylating enzymes--SENPs - PubMed
Review
. 2008 Nov;60(11):734-42.
doi: 10.1002/iub.113.
Affiliations
- PMID: 18666185
- DOI: 10.1002/iub.113
Free article
Review
DeSUMOylating enzymes--SENPs
Marcin Drag et al. IUBMB Life. 2008 Nov.
Free article
Abstract
Modification of proteins by ubiquitin and SUMO (small ubiquitin-like modifiers) is a dynamic and reversible process. Similar to the ubiquitin pathway, where the action of deubiquitinating enzymes removes ubiquitin from ubiquitin-adducts, SUMO is also removed intact from its substrates by proteases belonging to the sentrin-specific proteases (SENPs) family. In addition to their isopeptidase activity, SENPs also execute another essential function as endopeptidases by removing the short C-terminal extension from immature SUMOs. The defining characteristics of SENPs are their predicted conserved molecular scaffold-defined as members of peptidase Clan CE, conserved catalytic mechanism, and their reported activity on SUMO or Nedd8 conjugated proteins (or the respective precursors). We discuss recent progress on the human SENPs and their substrates.
Copyright (c) 2008 IUBMB
Similar articles
-
Drag M, Mikolajczyk J, Krishnakumar IM, Huang Z, Salvesen GS. Drag M, et al. Biochem J. 2008 Jan 15;409(2):461-9. doi: 10.1042/BJ20070940. Biochem J. 2008. PMID: 17916063
-
Characterization of SENP7, a SUMO-2/3-specific isopeptidase.
Shen LN, Geoffroy MC, Jaffray EG, Hay RT. Shen LN, et al. Biochem J. 2009 Jun 26;421(2):223-30. doi: 10.1042/BJ20090246. Biochem J. 2009. PMID: 19392659
-
Mikolajczyk J, Drag M, Békés M, Cao JT, Ronai Z, Salvesen GS. Mikolajczyk J, et al. J Biol Chem. 2007 Sep 7;282(36):26217-24. doi: 10.1074/jbc.M702444200. Epub 2007 Jun 25. J Biol Chem. 2007. PMID: 17591783
-
SUMO-specific proteases: a twist in the tail.
Hay RT. Hay RT. Trends Cell Biol. 2007 Aug;17(8):370-6. doi: 10.1016/j.tcb.2007.08.002. Epub 2007 Sep 4. Trends Cell Biol. 2007. PMID: 17768054 Review.
-
Leach CA, Tian X, Mattern MR, Nicholson B. Leach CA, et al. Methods Mol Biol. 2009;497:269-81. doi: 10.1007/978-1-59745-566-4_18. Methods Mol Biol. 2009. PMID: 19107424 Review.
Cited by
-
Schulz S, Chachami G, Kozaczkiewicz L, Winter U, Stankovic-Valentin N, Haas P, Hofmann K, Urlaub H, Ovaa H, Wittbrodt J, Meulmeester E, Melchior F. Schulz S, et al. EMBO Rep. 2012 Oct;13(10):930-8. doi: 10.1038/embor.2012.125. Epub 2012 Aug 10. EMBO Rep. 2012. PMID: 22878415 Free PMC article.
-
SENP3 loss promotes M2 macrophage polarization and breast cancer progression.
Xiao M, Bian Q, Lao Y, Yi J, Sun X, Sun X, Yang J. Xiao M, et al. Mol Oncol. 2022 Feb;16(4):1026-1044. doi: 10.1002/1878-0261.12967. Epub 2021 May 29. Mol Oncol. 2022. PMID: 33932085 Free PMC article.
-
SUMOylation Is Required for ERK5 Nuclear Translocation and ERK5-Mediated Cancer Cell Proliferation.
Erazo T, Espinosa-Gil S, Diéguez-Martínez N, Gómez N, Lizcano JM. Erazo T, et al. Int J Mol Sci. 2020 Mar 23;21(6):2203. doi: 10.3390/ijms21062203. Int J Mol Sci. 2020. PMID: 32209980 Free PMC article.
-
The pCri System: a vector collection for recombinant protein expression and purification.
Goulas T, Cuppari A, Garcia-Castellanos R, Snipas S, Glockshuber R, Arolas JL, Gomis-Rüth FX. Goulas T, et al. PLoS One. 2014 Nov 11;9(11):e112643. doi: 10.1371/journal.pone.0112643. eCollection 2014. PLoS One. 2014. PMID: 25386923 Free PMC article.
-
Novel insights into the impact of the SUMOylation pathway in hematological malignancies (Review).
Wang L, Qian J, Yang Y, Gu C. Wang L, et al. Int J Oncol. 2021 Sep;59(3):73. doi: 10.3892/ijo.2021.5253. Epub 2021 Aug 9. Int J Oncol. 2021. PMID: 34368858 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous